NASDAQ · Healthcare · Biotechnology
Corcept Therapeutics Incorporated
CORT
Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. CEO Joseph K. Belanoff · Market cap $6.1B.
$57.08
+5.92 · +11.57%
52w hi $91.0052w lo $28.66
Off 52w high 49.4%
59
ROUTINE
Current InsiderScore
Corp · 90d
2
2 buys · 0 sales
Cong · 90d
0
0 buys · 0 sales
Signals ≥ 60 · 12mo
0
0 strong · 0 notable
Analyst consensus
Strong Buy
Avg PT $68.40
Section 01
Recent Form 4 filings
3 filings on file
| Date | Insider | Role | Action | Shares | Price | Value | Score |
|---|---|---|---|---|---|---|---|
| Mar 17 | Leonard G Baker JR | Buy | 24,218 | $33.56 | +$813K | 39 | |
| Mar 17 | Leonard G Baker JR | Buy | 75,782 | $33.00 | +$2.50M | 59 | |
| May 16 | David L Mahoney | Sell | 23,829 | $74.17 | −$1.77M | 35 |
Section 02
Recent STOCK Act disclosures
No disclosures yet
No STOCK Act disclosures on record for this ticker.
Section 03
InsiderScore history
Rolling 12 months · peak score per month
JunJulAugSepOctNovDecJanFebMarAprMay